ArticleJournal of translational medicine2015

Increased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonance spectroscopy.

Jack J A van Asten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.